These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33348276)

  • 1. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
    van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
    Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
    Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
    Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
    Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.
    Bennett A; Gnjidic D; Gillett M; Carroll P; Matthews S; Johnell K; Fastbom J; Hilmer S
    Drugs Aging; 2014 Mar; 31(3):225-32. PubMed ID: 24452921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the Mohammed V Military Teaching Hospital in Morocco.
    Fettah H; Moutaouakkil Y; Sefrioui MR; Moukafih B; Bousliman Y; Bennana A; Lamsaouri J; Makram S; Cherrah Y
    Pan Afr Med J; 2018; 29():225. PubMed ID: 30100979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
    Goh I; Lai O; Chew L
    Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
    Kim SH; Suh Y; Ah YM; Jun K; Lee JY
    Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions in cancer chemotherapy: an observational study in a tertiary health care centre.
    Singh H; Singh B
    Drug Metab Pers Ther; 2017 Dec; 32(4):219-223. PubMed ID: 29135452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors.
    Oliveira RF; Oliveira AI; Cruz AS; Ribeiro O; Afreixo V; Pimentel F
    BMC Geriatr; 2024 Jun; 24(1):557. PubMed ID: 38918696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital.
    Aljadani R; Aseeri M
    BMC Res Notes; 2018 Apr; 11(1):234. PubMed ID: 29622031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity and management of drug-drug interactions in acute geriatric patients.
    Lea M; Rognan SE; Koristovic R; Wyller TB; Molden E
    Drugs Aging; 2013 Sep; 30(9):721-7. PubMed ID: 23681400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
    Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
    Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study.
    Khan Q; Ismail M; Khan S
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):75. PubMed ID: 29191244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
    Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
    Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.